Cancer Health Treatment Update What Acupuncture Can Do There is good evidence that acupuncture helps alleviate chemotherapy-related neuropathy and nausea.  FDA Approves Erleada for Hormone-Sensitive Prostate Cancer Two androgen receptor inhibitors improved survival by 33% in men with metastatic prostate cancer that responds to hormone therapy. Tumor Mutation Burden Does Not Predict Immunotherapy Response Biomarker was not linked to response rates in two studies of Keytruda for lung cancer. How Carcinogens Are Getting Into Over-the-Counter Medications The FDA has found a probable cancer-causing contaminant in generic drugs shipped from abroad––most recently, Zantac. News From the World Conference on Lung Cancer All of Cancer Health's coverage of the world's biggest lung cancer conference. Cancer Health Fall 2019 Check out our latest print edition! Advertisement Treatment News FDA Approves Erleada for Hormone-Sensitive Prostate Cancer “Curative Potential” of a Combination Therapy for Some Leukemia Patients Scientists Take First Step Toward Using CRISPR to Cure HIV in Humans Experts Call For Smoking Cessation After Cancer Diagnosis Blog: National Cancer Institute Altering Diet Enhances Response to Cancer Treatments in Mice Transforming the Pediatric Cancer Landscape Through Sharing Data Study Tests Immunotherapy in People With Cancer and Autoimmune Diseases Newly Discovered ‘Don’t Eat Me’ Signal May Be Cancer Immunotherapy Target Treatment News FDA Approves Erleada for Hormone-Sensitive Prostate Cancer “Curative Potential” of a Combination Therapy for Some Leukemia Patients Scientists Take First Step Toward Using CRISPR to Cure HIV in Humans Experts Call For Smoking Cessation After Cancer Diagnosis Blog: National Cancer Institute Altering Diet Enhances Response to Cancer Treatments in Mice Transforming the Pediatric Cancer Landscape Through Sharing Data Study Tests Immunotherapy in People With Cancer and Autoimmune Diseases Newly Discovered ‘Don’t Eat Me’ Signal May Be Cancer Immunotherapy Target

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: